| 标题 |
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of clinical oncology : official journal of the American Society of Clinical Oncology 作者:Heymach JV; Opdam F; Barve M; Tu HY; Wu YL; et al 出版日期:2025/04/10 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)